FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely pulmonology, and aims at diagnosing autoimmune inflammation in newly diagnosed patients with sarcoidosis. Method consists in determining the level of autoantibodies to modified citrullinated vimentin (anti-MCV) and B-cell level. If the anti-MCV increase is 10 units/ml and higher, and the CD5 + CD27 level is more than 12.45 %, and if the ratio of naive B cells to the memory cells is more than 2:1, autoimmune inflammation is diagnosed.
EFFECT: use of the invention provides a high level of specificity (88 %) and sensitivity (91 %) and enables the timely prescription of a pathogenetic therapy, which improves clinical course, prevents chronic course and reduces the number of recurrences.
1 cl, 2 dwg, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PEMPHIGUS SIMULATION METHOD FOR MICE BY IMMUNOGLOBULIN G ADMINISTRATION | 2015 |
|
RU2613718C1 |
METHOD FOR PLATELET AUTOANTIBODY TEST | 2012 |
|
RU2488114C1 |
DIAGNOSTIC TECHNIQUE FOR RHEUMATOID ARTHRITIS IF MUTATED CITRULLINATED VIMENTIN ANTIBODIES (Anti-MCV) ARE FOUND IN ORAL FLUID | 2012 |
|
RU2523413C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF RELAPSE IN THE MEDICAL TREATMENT OF GRAVES' DISEASE | 2021 |
|
RU2778614C1 |
METHOD OF DETERMINING THE CONVERSION OF THE MOLECULAR BIOLOGICAL SUBTYPE OF THE TOTALITY OF CIRCULATING TUMOR CELLS RELATIVE TO THE MOLECULAR BIOLOGICAL SUBTYPE OF THE PRIMARY TUMOR IN PATIENTS WITH BREAST CANCER | 2022 |
|
RU2797698C1 |
METHOD FOR DETERMINING AND ASSESSING LOCAL IMMUNITY IN PATIENTS WITH PSORIASIS | 2022 |
|
RU2804243C1 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS AND SJOGREN DISEASE | 2023 |
|
RU2817079C1 |
METHOD FOR DIAGNOSING ALLERGIC BRONCHIAL ASTHMA | 2021 |
|
RU2780687C1 |
METHOD OF PRODUCING SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES-IgG TO DESMOGLEIN OF TYPE 3 FROM BLOOD SERUM OF PATIENTS WITH PEMPHIGUS | 2015 |
|
RU2622005C2 |
METHOD FOR EVALUATING THE PRO-INFLAMMATORY ACTIVITY OF MONOCYTES | 2021 |
|
RU2755493C1 |
Authors
Dates
2020-12-23—Published
2019-12-30—Filed